[1]郭铁,雷励△,程平荣,等.补肾活血片治疗血管性痴呆60例[J].西部中医药,2019,32(06):75-77.
 GUO Tie,LEI Li,CHENG Pingrong,et al.Treatment for 60 Cases of Vascular Dementia by Kidney-invigorating Blood-activating Tablets[J].Western Journal of Traditional Chinese Medicine,2019,32(06):75-77.
点击复制

补肾活血片治疗血管性痴呆60例
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
32
期数:
2019年06期
页码:
75-77
栏目:
报道·临证经验
出版日期:
2019-06-15

文章信息/Info

Title:
Treatment for 60 Cases of Vascular Dementia by Kidney-invigorating Blood-activating Tablets
文章编号:
1004-6852(2019)06-0075-03
作者:
郭铁雷励△程平荣陈焱彬
重庆市北碚区中医院脑病一科,重庆 400700
Author(s):
GUO Tie LEI Li△ CHENG Pingrong CHEN Yanbin
The First Department of Encephalopathy, Beibei TCM Hospital, Chongqing 400700, China
关键词:
血管性痴呆补肾活血片认知功能生活质量
Keywords:
vascular dementia kidney-invigorating blood-activating tablets cognitive function quality of life
分类号:
R255.2
文献标志码:
B
摘要:
目的:观察补肾活血片治疗血管性痴呆的临床疗效。方法:将120例患者随机分为观察组和对照组,每组60例。2组均给予血管性痴呆患者常规疗法治疗。对照组同时服用胞磷胆碱片,0.2 g/次,3次/d;观察组同时服用补肾活血片,4片/次,3次/d,比较临床疗效,并利用长谷川痴呆量表(HDS)、日常生活能力量表(ADL)和简易精神状况评价量表(MMSE)比较2组患者的HDS、ADL和MMSE评分。结果:总有效率观察组为93.33%,对照组为73.33%,2组比较差异有统计学意义(P<0.05)。不良反应发生率观察组为3.33%,对照组为8.33%,2组比较差异有统计学意义(P<0.05)。HDS及ADL评分治疗前后2组组内比较,差异有统计学意义(P<0.05);治疗后组间比较差异也有统计学意义(P<0.05)。MMSE评分治疗后2组比较,差异有统计学意义(P<0.05)。结论:补肾活血片可有效提高血管性痴呆患者的临床治疗效果,改善患者HDS、ADL和MMSE评分。
Abstract:
Objective: To observe clinical effects of kidney-invigorating blood-activating tablets in treating vascular dementia (VD). Methods: All 120 patients were allocated to two groups, both groups accepted conventional therapy of VD, the control group took citicoline tablets simultaneously, three times each day, 0.2 g each time; the observation group were given kidney-invigorating blood-activating tablets four pills each time, three times each day. To compare clinical effects, HDS scores, ADL and MMSE scores between both groups. Results: Total effective rate of the observation group was 93.33%, higher than 73.33% of the control group, and the difference showed statistical meaning (P<0.05). The incidence of adverse reaction in the observation group was 3.33%, lower than 8.33% of the control group, and the difference was statistically significant (P<0.05). The difference was statistically significant in the comparisons of HDS and ADL scores within two groups before and after treating (P<0.05); the difference could be found between both groups after treating (P<0.05). The difference was statistically significant in MMSE scores between both groups after treating (P<0.05). Conclusion: Kidney-invigorating blood-activating tablets could raise therapeutic effects of VD patients, improve HDS, ADL and MMSE scores.

相似文献/References:

[1]李伟伟,王鸣池,于盼盼,等.奥拉西坦联合三七通舒治疗血管性痴呆的临床疗效观察[J].西部中医药,2013,26(02):81.
 LI Weiwei,WANG Mingchi,YU Panpan,et al.Observation on Clinical Effects of Oxiracetam Capsule and SanQi TongShu Capsule in Treating Vascular Dementia[J].Western Journal of Traditional Chinese Medicine,2013,26(06):81.
[2]高晓兰,朱增强,陈彦文,等.当归补血汤加味对血管性痴呆大鼠的脑保护作用研究[J].西部中医药,2013,26(04):22.
 GAO Xiaolan,ZHU Zengqiang,CHEN Yanwen,et al.Study on Modified DangGui BuXueTang to Cerebral Protection of Rats with Vascular Dementia[J].Western Journal of Traditional Chinese Medicine,2013,26(06):22.
[3]王保平,张圆,陈怡名,等.龙首参葛丸对血管性痴呆大鼠海马CA1区组织结构变化的影响[J].西部中医药,2019,32(06):6.
 WANG Baoping,ZHANG Yuan,CHEN Yiming,et al.Impact of LongShou ShenGe Pills on the Structural Changes of the Tissue in Hippocampal CAI Region of the Rat with Vascular Dementia[J].Western Journal of Traditional Chinese Medicine,2019,32(06):6.
[4]张慧,张婷,陈锐,等.醒脑方对血管性痴呆大鼠脑组织学习记忆能力的保护作用[J].西部中医药,2020,33(07):20.[doi:10.12174/j.issn.1004-6852.2020.07.05]
 ZHANG Hui,ZHANG Ting,et al.Protective Effects of Xingnao Prescription on Learning and Memory Ability of Brain Tissue in VD Rats[J].Western Journal of Traditional Chinese Medicine,2020,33(06):20.[doi:10.12174/j.issn.1004-6852.2020.07.05]

备注/Memo

备注/Memo:
收稿日期:2018-10-21*基金项目:重庆市卫生局课题资助项目(编号2012-2-51)。作者简介:郭铁(1980—),男,副主任医师。研究方向:中医脑病的临床诊治。△通讯作者:雷励(1970—),女,主任医师。研究方向:中医脑病的临床诊治。
更新日期/Last Update: 2019-06-15